Search Results

Phase 2 Study Part 1 IPO Raises $161M for GPCR-Based Drug Developer Structure Therapeutics Crinetics Pharmaceuticals

Research Associate Research Technician Senior Research Associate, In Vitro Pharmacology - Crinetics Pharmaceuticals

Research Associate NEW Research Technician Senior Research Associate, In Vitro Pharmacology - Crinetics Pharmaceuticals

| Chemotactic Cytokines GPCR Jobs NEW Senior Research Associate, In Vitro Pharmacology - Crinetics Pharmaceuticals

strong sales growth and core margin expansion in Q2; raises FY 2024 bottom-line guidance Crinetics Pharmaceuticals

great conversation about this position with Beth Fleck, Director of In Vitro Pharmacology at Crinetics Pharmaceuticals

great conversation about this position with Beth Fleck, Director of In Vitro Pharmacology at Crinetics Pharmaceuticals

results for metabolic disorders INDIGO Biosciences, INC as a Preferred Supplier at Prendio Crinetics Pharmaceuticals

Industry News Design Pharmaceuticals has a new website Confo Therapeutics Announces Global Licensing

InterAx Biotech's AI platform unlocks new drug designs for diabetes, obesity, and cancer Crinetics Pharmaceuticals

extraordinary opportunity to generate proprietary chemo-informatics for GPCR drug discovery - Design Pharmaceuticals

., CEO and Founder of Crinetics Pharmaceuticals, as an Entrepreneur Of The Year® 2024 Pacific Southwest

17th, 2024 Industry News Centessa Launches Phase 2 Trial of ORX750 for Narcolepsy and IH Crinetics Pharmaceuticals

Industry News Josephine (Pina) Cardarelli from GPCR Therapeutics on Beyond Biotech Podcast Crinetics Pharmaceuticals

Mark discussed this position with Beth Fleck, Director of In Vitro Pharmacology at Crinetics Pharmaceuticals

spinning GPR68 small molecules into GIO New treatments being developed for schizophrenia Crinetics Pharmaceuticals

Can the pharmaceutical industry reduce attrition rates? Acta Pharmaceutica Sinica B. 2022;12(7):3049-3062. 6.            Wouters OJ, McKee M, Luyten J. Innovation in the pharmaceutical industry: New estimates of R&D costs.